Rua Bioscience

Rua is a New Zealand cannabis pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in the Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company in New Zealand to obtain a licence to cultivate cannabis for research purposes. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain.


Company Details

Registered Office: 1 Commerce Place, Awapuni, Gisborne 4071
Postal Address: 1 Commerce Place, Awapuni, Gisborne 4071
Telephone: +64-6-390-6938
Facsimile: n/a
Website: www.ruabio.com
First Listed: 22/10/2020
Balance Date: 30 June
AGM: 12/10/2022

Directors and Executives

Tony Barclay
Independent Director
Panapa Ehau
Executive Director
Teresa Farac-Ciprian Independent Non-Executive Director
Brett Gamble
Non-Executive Director
Paul Naske
Chief Executive Officer
Anna Stove
Chair
Hamish White
Chief Financial Officer

Announcements

Title Date Type
Changes to the Supply Agreement with Cann Group Mon, Dec 04 2023 09:48 am GENERAL
Global Market Expansion with Unique New Zealand Genetics Fri, Dec 01 2023 03:30 pm GENERAL
Results of 2023 Annual Shareholders' Meeting Wed, Oct 11 2023 11:50 am MEETING
Rua Bioscience ASM presentation and Speeches Wed, Oct 11 2023 09:54 am MEETING
SPH Notice - Hikurangi Enterprises Limited Tue, Oct 10 2023 02:25 pm SHINTR
Rua Releases Annual Report for Year Ended 30 June 2023 Fri, Sep 15 2023 08:30 am ANNREP
Rua Notice of 2023 Annual Shareholders' Meeting Wed, Sep 13 2023 02:11 pm MEETING
Launch of first product in Australia Tue, Sep 05 2023 08:30 am GENERAL
Supply line strengthens with Schroll Medical Agreement Thu, Aug 31 2023 09:30 am GENERAL
Rua Bioscience Annual Results Tue, Aug 29 2023 09:10 am FLLYR

Major Holdings Announcements

Date Name No. Held % Current
22/12/22 Michael John Wilding 8,509,556 - 5.39
18/03/22 Hikurangi Enterprises Limited 8,132,620 - 5.43
17/03/22 Hikurangi Bioactives Limited Partne 4,000,000 12.58 2.67
22/10/20 Tailorspace Capital Limited, Tailor 11,129,375 - 7.95
22/10/20 Fang Group Investment Limited and F 23,584,939 - 16.85
22/10/20 Andrew Charles Williams 7,756,838 - 5.54

Director’s Interests Announcements

Date Name No. Held % Details Other
31/05/23 Hamish White 80,895 - - -
17/05/23 Antony George Barclay 50,000 - - -
02/11/21 Paul Naske 159,872 - - -
02/11/21 Rob Mitchell 288,251 - - -
02/11/21 Panapa Ehau 474,224 - - -
02/11/21 Trevor Burt 958,002 - - -
22/10/20 Martin Smith 2,544,732 - - -
22/10/20 Brett Gamble 1,805,914 - - -
22/10/20 Anna Stove 763,896 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 06/06/2023


Markets News

NZ sharemarket lifts into positive territory for the year
Markets Market close

NZ sharemarket lifts into positive territory for the year

The S&P/NZX 50 Index closed at 11,496.61, up 33.12 points or 0.29%.

Markets

Air NZ’s 'small but mighty' step towards green aviation

The carrier has bought an all-electric aircraft from Beta Tech, to be delivered in 2026.

Air NZ’s 'small but mighty' step towards green aviation
Markets

Xero, Tourism Holdings, NZME among Deloitte Top 200 winners

The prestigious Deloitte Top 200 Awards winners were revealed on Wednesday evening.

Xero, Tourism Holdings, NZME among Deloitte Top 200 winners
Markets

ComCom: Is it time to deregulate fibre broadband?

The review is the first under a new regulatory regime.

ComCom: Is it time to deregulate fibre broadband?
Finance

Fonterra lifts payout, earning forecast

The lift comes after the recent lift in global prices.

Fonterra lifts payout, earning forecast